You have searched for "Hospitalizations"

Showing 1-10 of 56

Sort by: Newest | Oldest | Relevance

Business 16 Apr 2006 | 12:00 AM Premium

Bird flu threat breathes new life into moribund drug Relenza

CHICAGO (AP): Global fears over bird flu have sent sales soaring for an antiviral drug once dismissed as a commercial dud, but the two companies responsible for the drug are locked in a bitter court battle over profits.

Business 26 Jul 2009 | 12:00 AM Premium

California officials concerned about new budget woes

SACRAMENTO, California (AP): California officials are warily awaiting the next round of state revenue figures, concerned that their latest budget-balancing efforts may not be enough to end a seemingly endless stream of deficits.

Business 25 Jul 2011 | 12:00 AM Premium

Prices of some common medicines to go down

NEW YORK: The cost of prescription medicines used by millions of people all over the world every day is about to plummet.

Business 22 Oct 2012 | 12:00 AM Premium

Extra weight tied to higher risk of hospitalization: study

Regardless of lifestyle and other health-related factors, heavier people were more likely than lean ones to be hospitalized for a variety of conditions, according to an Australian study.

Business 06 Aug 2014 | 8:26 AM Premium

Expectations are building for a new heart failure drug from Novartis

LONDON: Expectations are building for a new heart failure drug from Novartis viewed as a likely multibillion-dollar seller, with two surveys of cardiologists published on Tuesday highlighting its potential. A large clinical trial with LCZ696 was stopped early in March because the benefit to patients was overwhelmingly positive. Just how good the drug was will be disclosed at a medical meeting in Spain at the end of this month.

Corporate News 04 Dec 2017 | 10:56 PM Premium

Trouble mounts for Sanofi dengue vaccine; approved in M'sia but not launched

The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization programme after the French drugmaker said it could actually worsen the disease in some cases. It is approved but not yet launched in Malaysia, Honduras, Australia, Argentina, Venezuela, Bolivia, Bangladesh and Cambodia.